VIR earnings: real EPS beat/miss history, analyst consensus Buy, P/E -2.99. Updated 2026-07-23.
Vir Biotechnology (VIR) Research Hub
Vir Biotechnology (VIR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 10.62 USD (-1.76%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.99, market cap 1.57B. This hub links to the full technical, earnings and options research available for VIR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 10.62 USD (-1.76%) |
| 52-week range | 8.52 USD – 11.74 USD |
| Trend regime | Range |
| 14-day RSI | 70.8 (Overbought) |
| Trailing P/E | -2.99 |
| Market cap | 1.57B |
| Dividend yield | 0.00% |
Available research for VIR
Covered Call on VIR: how it works, illustrative setup around the real 10.62 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on VIR: how it works, illustrative setup around the real 10.62 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on VIR: how it works, illustrative setup around the real 10.62 USD price, max profit/loss, breakeven and when to use it. Educational.
VIR technical analysis: range, last 10.62 USD, RSI 70.8, 52w range 8.52 USD–11.74 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is VIR in?
Vir Biotechnology (VIR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is VIR in an uptrend or downtrend?
As of 2026-09-11, VIR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is VIR's trailing P/E ratio?
VIR's trailing P/E is -2.99, with a market cap of 1.57B. See the earnings research page for full valuation detail.